Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lixin Wan

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Molecular Cell|January 21, 2018
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.
Molecular Cell|August 14, 2025
WITHDRAWN: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Nature Communications|January 19, 2018
The protective role of DOT1L in UV-induced melanomagenesisBo Zhu, Shuyang Chen, Hongshen Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 TrialRuinuo Jia, Tanyou Shan, Anping Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trialChunmei Bai, Yi Zheng, Meili Sun, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Molecular Cell|January 21, 2018
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.
Molecular Cell|August 14, 2025
WITHDRAWN: Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic FunctionLixin Wan, Kexin Xu, Yongkun Wei, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Nature Communications|January 19, 2018
The protective role of DOT1L in UV-induced melanomagenesisBo Zhu, Shuyang Chen, Hongshen Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 TrialRuinuo Jia, Tanyou Shan, Anping Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2025
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trialChunmei Bai, Yi Zheng, Meili Sun, et al.
Nature Medicine|January 22, 2025
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trialLin Shen, Yanqiao Zhang, Ziyu Li, et al.
Pageof 9